Understanding New Changes to the OVA1 Results Report (West Coast)
WEBINAR ENDED
Thursday, November 3, 2016 · 12:30 p.m.
· 30 minutes
Understanding New Changes to the OVA1 Results Report (West Coast)
Thursday, November 3, 2016 · 12:30 p.m. · Pacific Time (US & Canada)
About This Webinar
In an interactive webinar, our team will walk you through how to integrate the OVA1 score with ultrasound result for a better assessment of ovarian cancer risk when managing adnexal masses.
ASPiRA Labs is a wholly-owned, specialized women’s health reference laboratory of Vermillion, Inc. Its vision is to be the global leader in personalized medical management of gynecologic health to improve clinical outcomes for patients, physicians and payers. We pride ourselves on being at the forefront of women’s healthcare and ovarian cancer diagnosis.
ASPiRA Labs, a Vermillion Company, presents "PATHWAYS" a webinar series to educate providers and women about our products to improve ovarian cancer detection.